🇺🇸 FDA
Patent

US 10604565

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 10604565 (Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer) held by Julius-Maximilians-Universitat Wurzburg expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Julius-Maximilians-Universitat Wurzburg
Grant date
Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K39/395, A61K39/39533, A61K39/3955